Merck & Co., Inc. (MRK) Management presents at Leerink Partners 2024 Global Biopharma Conference (Transcript)

Merck & Co., Inc. (NYSE:MRK) Leerink Partners 2024 Global Biopharma Conference Call March 11, 2024 12:40 PM ET Company Participants Marjorie Green - SVP and Head of Oncology Peter Dannenbaum - VP, IR Conference Call Participants Daina Graybosch - Leerink Partners Daina Graybosch Hi, everyone. Thank you for coming to the session. My name is Daina Graybosch. I and my team cover immuno-oncology and beyond here at Leerink Partners. And I'm really excited to have a great oncology conversation with Merck. We have ...